{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T08:48:03Z","timestamp":1792054083171,"version":"4.4.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":211,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cmghjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.jcmgh.2026.101857","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:29:14Z","timestamp":1786033754000},"page":"101857","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dysbiosis-Associated Lysophosphatidic Acid Primes Immune Checkpoint Inhibitor\u2013Induced Intestinal Barrier Dysfunction via the Lysophosphatidic Acid Receptor 2\u2013Myosin Light Chain Kinase Axis"],"prefix":"10.1016","volume":"20","author":[{"given":"Lei","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianshang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanqi","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizhen","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunsheng","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rumeng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abduxukur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehua","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerrold R.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruolei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2605-5697","authenticated-orcid":false,"given":"Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcmgh.2026.101857_bib1","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.jcmgh.2026.101857_bib2","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41571-019-0218-0","article-title":"Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance","volume":"16","author":"Martins","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jcmgh.2026.101857_bib3","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.3461","article-title":"Immune-related adverse events after immune checkpoint inhibitors for melanoma among older adults","volume":"5","author":"Schonfeld","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jcmgh.2026.101857_bib4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.aan3706","article-title":"Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors","volume":"359","author":"Routy","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.jcmgh.2026.101857_bib5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1126\/science.aan4236","article-title":"Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients","volume":"359","author":"Gopalakrishnan","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.jcmgh.2026.101857_bib6","doi-asserted-by":"crossref","first-page":"10391","DOI":"10.1038\/ncomms10391","article-title":"Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis","volume":"7","author":"Dubin","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcmgh.2026.101857_bib7","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1200\/JCO.2017.77.6385","article-title":"Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American Society of Clinical Oncology clinical practice guideline","volume":"36","author":"Brahmer","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jcmgh.2026.101857_bib8","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.annonc.2022.10.001","article-title":"Management of toxicities from immunotherapy: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"33","author":"Haanen","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jcmgh.2026.101857_bib9","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/s41586-019-1162-y","article-title":"Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy","volume":"569","author":"Perez-Ruiz","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jcmgh.2026.101857_bib10","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1136\/gutjnl-2025-337780","article-title":"Targeting MLCK1 uncouples immune checkpoint inhibitor-induced colitis from antitumour immunity","volume":"75","author":"Xiong","year":"2026","journal-title":"Gut"},{"key":"10.1016\/j.jcmgh.2026.101857_bib11","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/s41591-019-0393-7","article-title":"Intracellular MLCK1 diversion reverses barrier loss to restore mucosal homeostasis","volume":"25","author":"Graham","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.jcmgh.2026.101857_bib12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1749-6632.2012.06526.x","article-title":"Myosin light chain kinase: pulling the strings of epithelial tight junction function","volume":"1258","author":"Cunningham","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jcmgh.2026.101857_bib13","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0002-9440(10)62264-X","article-title":"Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression","volume":"166","author":"Wang","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jcmgh.2026.101857_bib14","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/gutjnl-2021-326534","article-title":"Tacrolimus-binding protein FKBP8 directs myosin light chain kinase-dependent barrier regulation and is a potential therapeutic target in Crohn\u2019s disease","volume":"72","author":"Zuo","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.jcmgh.2026.101857_bib15","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMra1703481","article-title":"Immune-related adverse events associated with immune checkpoint blockade","volume":"378","author":"Postow","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcmgh.2026.101857_bib16","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1001\/jamaoncol.2018.3923","article-title":"Fatal toxic effects associated with immune checkpoint inhibitors: a systematic review and meta-analysis","volume":"4","author":"Wang","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jcmgh.2026.101857_bib17","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.3390\/ijms24032769","article-title":"Implication of the gut microbiome and microbial-derived metabolites in immune-related adverse events: emergence of novel biomarkers for cancer immunotherapy","volume":"24","author":"Dora","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcmgh.2026.101857_bib18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrgastro.2012.14","article-title":"IBD-what role do Proteobacteria play?","volume":"9","author":"Mukhopadhya","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101857_bib19","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20232079","article-title":"Baseline colitogenicity and acute perturbations of gut microbiota in immunotherapy-related colitis","volume":"222","author":"Shang","year":"2025","journal-title":"J Exp Med"},{"key":"10.1016\/j.jcmgh.2026.101857_bib20","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1186\/s12967-025-06586-0","article-title":"Gut microbiome changes and cancer immunotherapy outcomes associated with dietary interventions: a systematic review of preclinical and clinical evidence","volume":"23","author":"Somodi","year":"2025","journal-title":"J Transl Med"},{"key":"10.1016\/j.jcmgh.2026.101857_bib21","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1038\/s41467-020-16079-x","article-title":"Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer","volume":"11","author":"Coutzac","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcmgh.2026.101857_bib22","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.chom.2017.09.006","article-title":"Epithelial-cell-derived phospholipase A2 group 1B is an endogenous anthelmintic","volume":"22","author":"Entwistle","year":"2017","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jcmgh.2026.101857_bib23","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s42255-024-01177-7","article-title":"Intestinal TM6SF2 protects against metabolic dysfunction-associated steatohepatitis through the gut-liver axis","volume":"7","author":"Zhang","year":"2025","journal-title":"Nat Metab"},{"key":"10.1016\/j.jcmgh.2026.101857_bib24","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1053\/j.gastro.2021.08.041","article-title":"High-fat diet promotes colorectal tumorigenesis through modulating gut microbiota and metabolites","volume":"162","author":"Yang","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2026.101857_bib25","doi-asserted-by":"crossref","first-page":"11641","DOI":"10.1096\/fj.202000544R","article-title":"LPAR2 receptor activation attenuates radiation-induced disruption of apical junctional complexes and mucosal barrier dysfunction in mouse colon","volume":"34","author":"Shukla","year":"2020","journal-title":"FASEB J"},{"key":"10.1016\/j.jcmgh.2026.101857_bib26","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1053\/j.gastro.2007.03.038","article-title":"The lysophosphatidic acid type 2 receptor is required for protection against radiation-induced intestinal injury","volume":"132","author":"Deng","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2026.101857_bib27","doi-asserted-by":"crossref","first-page":"12037","DOI":"10.1074\/jbc.M109.064808","article-title":"Epithelial myosin light chain kinase activation induces mucosal interleukin-13 expression to alter tight junction ion selectivity","volume":"285","author":"Weber","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jcmgh.2026.101857_bib28","doi-asserted-by":"crossref","first-page":"55506","DOI":"10.1074\/jbc.M408822200","article-title":"A differentiation-dependent splice variant of myosin light chain kinase, MLCK1, regulates epithelial tight junction permeability","volume":"279","author":"Clayburgh","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jcmgh.2026.101857_bib29","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1053\/j.gastro.2021.08.047","article-title":"The tight junction protein ZO-1 is dispensable for barrier function but critical for effective mucosal repair","volume":"161","author":"Kuo","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2026.101857_bib30","doi-asserted-by":"crossref","first-page":"17317","DOI":"10.1074\/jbc.RA118.003908","article-title":"The scaffolding protein ZO-1 coordinates actomyosin and epithelial apical specializations in vitro and in vivo","volume":"293","author":"Odenwald","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jcmgh.2026.101857_bib31","doi-asserted-by":"crossref","first-page":"8237","DOI":"10.1073\/pnas.0908869107","article-title":"MLCK-dependent exchange and actin binding region-dependent anchoring of ZO-1 regulate tight junction barrier function","volume":"107","author":"Yu","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcmgh.2026.101857_bib32","first-page":"243","article-title":"ZO-1 interactions with F-actin and occludin direct epithelial polarization and single lumen specification in 3D culture","volume":"130","author":"Odenwald","year":"2017","journal-title":"J Cell Sci"},{"key":"10.1016\/j.jcmgh.2026.101857_bib33","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1053\/j.gastro.2019.07.058","article-title":"Inflammation-induced occludin downregulation limits epithelial apoptosis by suppressing caspase-3 expression","volume":"157","author":"Kuo","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2026.101857_bib34","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1053\/j.gastro.2013.04.011","article-title":"TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis","volume":"145","author":"Su","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2026.101857_bib35","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1083\/jcb.200902153","article-title":"Caveolin-1-dependent occludin endocytosis is required for TNF-induced tight junction regulation in vivo","volume":"189","author":"Marchiando","year":"2010","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jcmgh.2026.101857_bib36","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/cncr.32542","article-title":"Health care utilization and steroid-refractory toxicities from immune checkpoint inhibitors","volume":"126","author":"Wang","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.jcmgh.2026.101857_bib37","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1200\/JCO.21.01440","article-title":"Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO guideline update","volume":"39","author":"Schneider","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jcmgh.2026.101857_bib38","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1572-0241.2006.00524.x","article-title":"Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up","volume":"101","author":"Baumgart","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jcmgh.2026.101857_bib39","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1200\/JCO.2018.79.0006","article-title":"Impact of baseline steroids on efficacy of programmed cell death-1 and programmed death-ligand 1 blockade in patients with non-small-cell lung cancer","volume":"36","author":"Arbour","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jcmgh.2026.101857_bib40","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1093\/cid\/ciw539","article-title":"The spectrum of serious infections among patients receiving immune checkpoint blockade for the treatment of melanoma","volume":"63","author":"Del Castillo","year":"2016","journal-title":"Clin Infect Dis"}],"container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X26001359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X26001359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T08:19:43Z","timestamp":1792052383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352345X26001359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2352345X26001359"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmgh.2026.101857","relation":{},"ISSN":["2352-345X"],"issn-type":[{"value":"2352-345X","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dysbiosis-Associated Lysophosphatidic Acid Primes Immune Checkpoint Inhibitor\u2013Induced Intestinal Barrier Dysfunction via the Lysophosphatidic Acid Receptor 2\u2013Myosin Light Chain Kinase Axis","name":"articletitle","label":"Article Title"},{"value":"Cellular and Molecular Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmgh.2026.101857","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Gastroenterological Association Institute.","name":"copyright","label":"Copyright"}],"article-number":"101857"}}